Gallus Biopharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Gallus Biopharmaceuticals Ownership

Who owns Gallus Biopharmaceuticals?

Gallus Biopharmaceuticals is owned by DPx Holdings BV. It was acquired on August 27, 2014.

Was Gallus Biopharmaceuticals formerly PE-backed?

Yes. Gallus Biopharmaceuticals was formerly owned by 1 private investor.

Gallus Biopharmaceuticals Business Overview

Where is Gallus Biopharmaceuticals headquartered?

Gallus Biopharmaceuticals is headquartered in St. Louis, Montana.

What sector is Gallus Biopharmaceuticals in?

Gallus Biopharmaceuticals is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Subscribe to Mergr to view all 241 acquisitions of life science companies in 2014, including 25 acquisitions by private equity firms, and 216 by strategics.

Acquired by DPx Holdings BV (Company) on 2014-08-27

Gallus Biopharmaceuticals LLC

4766 LaGuardia Drive,
St. Louis, Montana 63134-3117
United States,
(314) 426-5000
www.gallusbiopharma.com

Gallus BioPharmaceuticals is a contract manufacturing company offering exceptional contract services to its clients. Gallus’ world-class facility in St. Louis is distinguished by nearly three decades of biologics development and over a decade of commercial cGMP manufacturing, including the ongoing manufacture of Remicade® and Stelara® for Janssen Pharmaceuticals.

Company Summary

SECTOR

Subsidiary of

DPx Holdings BV

Investor History
2014-08-27
Add-on Acquisition

DPx Holdings BV

Ridgemont Equity Partners PE
2011-05-18
Buyout (LBO, MBO, MBI)

Ridgemont Equity Partners PE

Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.7K Private Equity Firms
208K M&A Transactions
210K Companies Involved in M&A
(Buyer, Seller, or Target)
3.7K M&A Advisors
(Investment Banks and Law Firms)
81K M&A Contacts
(PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Gallus Biopharmaceuticals

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies